Related Experiment Video
Updated: Jan 23, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Vitamin D downregulates key genes of diabetes complications in cardiomyocyte
Hoda Derakhshanian1,2, Abolghassem Djazayery3, Mohammad Hassan Javanbakht4
1Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Objective:
Vitamin D deficiency has been reported to be associated with the incidence of type 1 and type 2 diabetes and worsening of diabetes complications. This study was designed to investigate the effect of vitamin D treatment on the expression of five key genes involved in the development of diabetic cardiomyopathy.
Methods:
Twenty-four male Sprague-Dawley rats were randomly divided into three groups. The first group served as control and the other two groups received an intraperitoneal injection of 45 mg/kg streptozotocin (STZ) to develop diabetes. Then groups were treated for 4 weeks either with placebo or vitamin D (two injections of 20,000 IU/kg). Serum levels of glucose, insulin, HbA1c, and advanced glycation end products (AGEs), as well as the gene expression of AGE cellular receptor (RAGE), glyoxalase, aldose reductase, O-GlcNAc transferase (OGT), and glutamine-fructose-6-phosphate aminotransferase (GFAT) and nuclear factor-kB (NF-kB) activity of nuclear extracts were assessed at the end of experiment.
Results:
Increment in serum cholecalciferol could improve hyperglycaemia and hypoinsulinemia in diabetic rats. In addition, a significant reduction was observed in RAGE, OGT, and GFAT gene expression and NF-kB activity in cardiac myocytes.
Conclusions:
Vitamin D might contribute in reducing diabetic cardiomyopathy not only by improving blood glucose and insulin levels but also via downregulating AGE and hexosamine pathways and decreasing NF-kB activity in heart tissue.
Insights
Vitamin D treatment improved hyperglycemia and hypoinsulinemia in diabetic rats. It also reduced key gene expression linked to diabetic cardiomyopathy, suggesting a protective role.
Area of Science:
- Endocrinology
- Cardiovascular Research
- Molecular Biology
Background:
- Vitamin D deficiency is linked to diabetes incidence and complications.
- Diabetic cardiomyopathy is a significant concern in diabetes management.
Purpose of the Study:
- To investigate the effect of vitamin D on gene expression in diabetic cardiomyopathy.
- To assess vitamin D's impact on pathways involved in diabetes complications.
Main Methods:
- Streptozotocin-induced diabetes in Sprague-Dawley rats.
- Treatment with vitamin D or placebo for 4 weeks.
- Assessed serum markers, gene expression (RAGE, OGT, GFAT), and NF-kB activity.
Main Results:
- Vitamin D improved hyperglycemia and hypoinsulinemia.
- Reduced expression of RAGE, OGT, and GFAT genes was observed.
- Decreased nuclear factor-kB (NF-kB) activity in cardiac myocytes.
Conclusions:
- Vitamin D may reduce diabetic cardiomyopathy by improving glycemic control.
- Downregulation of AGE and hexosamine pathways contributes to the protective effect.
- Reduced NF-kB activity in heart tissue is a key mechanism.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Vitamins
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Hemodialysis II: Procedure and Complications

